European Primary Care Cardiovascular Society

Striking results for weight reduction in T2DM in primary care based program

Dec. 18, 2017 - IDF 2017 - Abu Dhabi, UAE - Prof Naveed Sattar, MD - Glasgow, UK

Clinical outcomes and adverse effects comparable across various BP measurement methods in SPRINT

Nov. 20, 2017 - AHA 2017 - Anaheim, CA, USA - Dr. Sripal Bangalore - NYU Langone, New York, NY, USA.

Good BP measurement depends more on appropriate technique than on absence of staff

Nov. 25, 2017 - AHA 2017 - Anaheim, CA, USA - Prof Karen Johnson - Memphis, TN, VS

Things to consider when aiming to prevent stroke in a patient with AF

May 25, 2017

What can be learned from the latest hypertension trials?

May 26, 2017

Heart failure diagnosis and management varies substantially across European countries

May 25, 2017

How do the latest guideline changes affect management of dyslipidaemia in primary care?

May 26, 2017

Ingredients of effective strategies to stimulate behaviour change

May 25, 2017

The evidence base for health behaviour changes

Dec. 9, 2015 - EPCCS 2015 - Prague, Czech Republic

Identifying and treating patients with true hypertension

Feb. 24, 2016 - Prague - EPCCS 2015

What is the evidence base for lipid modification in the guidelines updates?

Feb. 24, 2016 - Prague - EPCCS 2015

Heart failure diagnosis and management

Dec. 9, 2015 - EPCCS 2015 - Prague

​Stroke prevention in atrial fibrillation

Mar. 12, 2014 - Amsterdam - Hobbs, Rutten

The EPCCS Stroke Prevention in Atrial Fibrillation Guidance Document 1

Jan. 7, 2014 - EPCCS 2014, Brussels - Prof. David Fitzmaurice

What's the evidence for BP and lipid targets in diabetes?

Nov. 25, 2014 - EPCCS 2014, Brussels

Debate: should we treat lifetime risk or 10-year risk?

Nov. 25, 2014 - Brussels, Belgium - Prof R. Hobbs, Th. Christiaens, C.Brotons & A. Hoes - EPCCS 2014

Alcohol as a risk factor for hypertension

Nov. 20, 2014 - Brussels, Belgium - Prof. Daniel Duprez (Minnesota, USA) - EPCCS 2014

Reducing weight and increasing exercise - is it feasible?

Nov. 20, 2014 - Brussels, Belgium - Dr. Ian Campbell - EPCCS 2014

CVD and co-morbidities: What are the priorities? 1

Nov. 20, 2014 - EPCCS Brussels - Dr Geert-Jan Geersingh - EPCCS 2014

Diagnosis and management of acute coronary syndromes

Nov. 18, 2014 - Brusselss, Belgium - Dr. Frans Rutten - EPCCS 2014

Second EPCCS Council Meeting: expanding the impact for European GPs

Mar. 15, 2018 - news
Already at the second Council meeting, we shift gears from making plans to taking action and bringing the support of the European Primary Cardiovascular Care Community to a higher level.

EPCCS Council Already at the second Council meeting, we shift gears from making plans to taking action and bringing the support of the European Primary Cardiovascular Care Community to a higher level.

MACE safely reduced by another PCSK9 inhibitor in long term outcomes trial in high-risk patients

Presented at ACC.18 by Ph. Gabriel Steg (Paris, France)

Mar. 13, 2018 - news

ACC 2018 Treatment with alirocumab on top of high-intensity statins lowered MACE by 15% in patients with recent ACS in the ODYSSEY OUTCOMES trial and was associated with a lower rate of all-cause death.

Rate of AF diagnosis improves by self-applied ECG patch

Presented at ACC.18 by Steven Steinhubl (La Jolla, CA, USA)

Mar. 13, 2018 - news

ACC 2018 In the digital mSToPS trial using patient-generated data, a wearable ECG patch improved the rate of AF diagnosis at 1 year compared to routine care.

In post-MI patients with low LVEF, wearable cardioverter-defibrillator reduces total mortality

Presented at ACC.18 by Jeffrey Olgin (San Francisco, CA, USA)

Mar. 13, 2018 - news

ACC 2018 In post-MI patients with a low LVEF, WCD reduced total mortality in the immediate post-MI period (<90 days), but not sudden cardiac death.

Reduction of major vascular events with IL-1β inhibitor in patients with CKD

Presented at ACC.18 by Paul Ridker (Boston, MA, USA)

Mar. 13, 2018 - news

ACC 2018 Treatment with canakinumab reduced MACE+ in patients with CKD in the CANTOS trial, with a stronger reduction in those who achieved on-treatment hsCRP<2 mg/mL compared to >2 mg/mL.

Complication risk in diabetes can be predicted with new stratification

Mar. 7, 2018 - Ahlqvist E et al. - Lancet Diab Endocrinol 2018

In a data-driven cluster analysis of 6 variables in adult patients with newly diagnosed diabetes, 5 categories of patients were identified with different characteristics and risks of complications.

The obesity paradox challenged by new data with regard to CVD morbidity and longevity

Mar. 6, 2018 - Khan SS, et al. - JAMA Cardiol 2018

Overweight and obese individuals have a significantly increased long-term risk for CVD morbidity, and a similar or shorter total longevity, compared with individuals with a normal BMI.

Children with a higher BMI have an increased risk of cardio-metabolic disease later in life

Mar. 1, 2018 - Geng T, et al. - Diabetes Care 2018

A genetic predisposition to higher childhood BMI was associated with an increased risk of type 2 diabetes, coronary artery disease, and cardio-metabolic traits in adult life.

Patients on chronic CV therapies experience medication-related burden on daily life aspects

Feb. 27, 2018 - van der Laan DM et al. - Int J Clin Pharm 2018

Complex long-term medication for CV diseases adversely affects various aspects of every-day life of patients, irrespective of whether they adhere to their treatment regimens or not.

Slides: Organisation of Primary Care in the Netherlands

Feb. 28, 2018 - Dr Eric Lambermon

Presentation held during the EPCCS Council 2017 aimed to provide an update on the role of primary care in CV risk management in different countries

Stimulating health behaviour changes to reduce cardiovascular risk in primary care

Scroll down to download a free copy

EPCCS Consensus Guidance for Primary Care
EPCCS Consensus Guidance for Primary Care

Lifestyle importantly contributes to preventable morbidity and mortality. This EPCCS guidance document outlines the presented evidence on ingredients of successful behaviour change strategies and motivational interviewing, as well as which CV risk behaviours and clinical outcomes may be improved with various types of strategies.

Increased mortality and morbidity risk in older ischemic stroke patients with diabetes

Feb. 21, 2018 - Echouffo-Tcheugui JB, et al. - Eur Heart J 2018

In patients with ischemic stroke ≥ 65 years, diabetes is associated with a higher risk of mortality, recurrent events, HF and hospitalisations.